Combined influence of illness duration and medication type on visual sensitivity in schizophrenia

被引:6
|
作者
de Almeida, Natalia L. [1 ]
Fernandes, Thiago P. [1 ]
Lima, Eveline H. [1 ]
Sales, Hemerson F. [1 ]
Santos, Natanael A. [1 ]
机构
[1] Univ Fed Paraiba UFPB, Lab Percepcao Neurociencias & Comportamento LPNeC, Joao Pessoa, Paraiba, Brazil
关键词
Schizophrenia; contrast sensitivity function; illness duration; antipsychotics; psychiatry;
D O I
10.1590/1516-4446-2018-0331
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Patients with schizophrenia have visual processing impairments. The main findings from the literature indicate that these deficits may be related to differences in paradigms, medications, and illness duration. This study is part of a large-scale study investigating visual sensitivity in schizophrenia. Here we aimed to investigate the combined effects of illness duration and antipsychotic use on contrast sensitivity function. Methods: Data were collected from 50 healthy controls and 50 outpatients with schizophrenia (classified according to illness duration and medication type) aged 20-45 years old. The contrast sensitivity function was measured for spatial frequencies ranging from 0.2 to 20 cycles per degree using linear sine-wave gratings. Results: Patients with an illness duration > 5 years had more pronounced deficits. Differences in the combined effects of illness duration and antipsychotic use were marked in patients on typical antipsychotics who had been ill > 10 years. No significant differences were found between typical and atypical antipsychotics in patients with an illness duration < 5 years. Conclusion: Visual impairment was related to both long illness duration and medication type. These results should be tested in further studies to investigate pharmacological mechanisms.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 50 条
  • [21] Telomere Length in Schizophrenia as a Function of Age and Illness Duration
    Wolkowitz, Owen M.
    Palmer, Barton W.
    Glorioso, Danielle
    Thompson, Wesley
    Epel, Elissa S.
    Lin, Jue
    Blackburn, Elizabeth
    Jeste, Dilip V.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S347 - S348
  • [22] Homocysteine levels in schizophrenia are associated with longer duration of illness
    Theochari, E.
    Nikolaou, S.
    Louki, F.
    Giannoulis, A.
    Kipreos, D.
    Tsaltas, E.
    Kontis, D.
    EUROPEAN PSYCHIATRY, 2019, 56 : S507 - S507
  • [23] Postural hypotension in type 1 diabetes: The influence of glycemic control and duration of illness
    Oduwole, O. A.
    Adeniyi, O. F.
    Esezebor, C. I.
    Ekure, E.
    Fajolu, I. B.
    Renner, J. K.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2014, 17 (02) : 140 - 144
  • [24] A RECONSIDERATION OF THE RELATION OF VENTRICULAR ENLARGEMENT TO DURATION OF ILLNESS IN SCHIZOPHRENIA
    WOODS, BT
    WOLF, J
    AMERICAN JOURNAL OF PSYCHIATRY, 1983, 140 (12): : 1564 - 1570
  • [25] Olfactory identification deficits in schizophrenia: Correlation with duration of illness
    Moberg, PJ
    Doty, RL
    Turetsky, BI
    Arnold, SE
    Mahr, RN
    Gur, RC
    Bilker, W
    Gur, RE
    AMERICAN JOURNAL OF PSYCHIATRY, 1997, 154 (07): : 1016 - 1018
  • [26] Identifying an empirically valid duration of illness criterion for schizophrenia
    Dudgeon, P
    Mackinnon, AJ
    McGorry, PD
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 188 - 188
  • [27] Brain function, structure and genomic data are linked but show different sensitivity to duration of illness and disease stage in schizophrenia
    Luo, Na
    Tian, Lin
    Calhoun, Vince D.
    Chen, Jiayu
    Lin, Dongdong
    Vergara, Victor M.
    Rao, Shuquan
    Yang, Jian
    Zhuo, Chuanjun
    Xu, Yong
    Turner, Jessica A.
    Zhang, Fuquan
    Sui, Jing
    NEUROIMAGE-CLINICAL, 2019, 23
  • [28] Influence of Duration of Schizophrenia on Antisaccade Performance
    Radant, Allen D.
    Braff, David
    Calkins, Monica
    Cadenhead, Kristin
    Dobie, Dorcas
    Freedman, Robert
    Green, Michael
    Greenwood, Tiffany
    Gur, Raquel
    Gur, Ruben
    Horan, William
    Light, Gregory
    Meichle, Sean
    Millard, Steve
    Olincy, Ann
    Nuechterlein, Keith
    Seidman, Larry
    Siever, Larry
    Silverman, Jeremy
    Stone, William
    Sprock, Joyce
    Swerdlow, Neal
    Tsuang, Ming
    Turetsky, Bruce
    Tsuang, Debby
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 237S - 237S
  • [29] A multi-site FMRI study of schizophrenia: Effects of illness type and duration on brain function and connectivity
    Clark, V.
    Manoach, D.
    Gollub, R.
    Ho, B. C.
    Lim, K. O.
    Burge, J.
    Lane, T.
    Andreasen, N. C.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 364 - 364
  • [30] Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia
    Holzinger, A
    Löffler, W
    Müller, P
    Priebe, S
    Angermeyer, MC
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2002, 190 (09) : 597 - 603